ROIV
Roivant Sciences Ltd. · Healthcare
Director Meghan Fitzgerald sold $349K of Roivant Sciences Ltd.
Sold$349,000
$34.90Price
10,000Shares
−19%Stake
What ROIV did after the filing
- The stock from Mon, Jul 6 open, $35.01
- +6.7%
- S&P 500, same days
- +2.5%
Measured over 30 trading days, to the Aug 18 close.
Traded Tue, Jun 30. Filed Thu, Jul 2, 7:03 PM ET, after the close. Returns use the Jul 6 open and the Aug 18 close. Not investment advice.